Skip to main content
Researchers in a lab examining a sample

Red Ribbon · Awareness month: September

Blood Cancer

Blood cancer includes leukemia, lymphoma and myeloma, each with different subtypes and treatment approaches. Learn how these cancers affect the body, the signs and risk factors to know, how they are diagnosed and treated, and how research is working toward better answers.

New U.S. cases of leukemia, lymphoma and myeloma expected in 2026
192,030
U.S. deaths from leukemia, lymphoma and myeloma expected in 2026
55,830
Leukemia, lymphoma and myeloma
3 main groups

About

What Blood Cancer Is

At NFCR, we believe understanding cancer is an important part of fighting it.

Blood cancers involve the blood, bone marrow or lymphatic and immune systems. Leukemia, lymphoma and myeloma are the three main groups.

These diseases affect different cells and parts of the body. Knowing the full name of your cancer and its subtype is an important starting point for understanding your care.

The main groups and how they differ

Types of Blood Cancer

The three main groups include distinct diagnoses. Your care team can explain which one applies to you.

  • Leukemia

    Cancer found in blood and bone marrow. Forms include acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).

  • Lymphoma

    Cancer affecting cells in the immune and lymphatic systems. Its two main groups are Hodgkin and non-Hodgkin lymphoma, with further subtypes within them.

  • Myeloma

    Cancer of plasma cells, which normally make antibodies. Because it often occurs at several sites in the bone marrow, it is commonly called multiple myeloma.

Understanding the full diagnosis: The broad term blood cancer does not describe every aspect of a person’s disease. Ask which type and subtype you have and which test results are important for your treatment discussions.

Behind every number is a person

By the numbers

These figures describe the scale and main groupings of blood cancer. Population estimates cannot predict an individual outcome.

  • 192,030New U.S. cases of leukemia, lymphoma and myeloma expected in 2026
  • 55,830U.S. deaths from leukemia, lymphoma and myeloma expected in 2026
  • 1.5 million+People living with or in remission from blood cancer in the U.S., in the published estimate
  • About 3 minutesApproximate average interval between new blood cancer diagnoses in the U.S.
  • 3Main groups of blood cancer: leukemia, lymphoma and myeloma
  • 2Main groups of lymphoma: Hodgkin and non-Hodgkin lymphoma

U.S. estimates for 2026 · Source: American Cancer Society

Changes that may signal blood cancer

Signs & Symptoms

Symptoms vary by diagnosis. Possible changes include:

  • Persistent tiredness or weakness

    Leukemia, lymphoma and myeloma can all cause fatigue.

  • Shortness of breath

    Breathlessness can occur with leukemia or lymphoma.

  • Bruising or bleeding

    Unusual bruises, nosebleeds or bleeding gums can occur with leukemia; lymphoma can also cause easy bruising or bleeding.

  • Fever, night sweats or infections

    Unexplained fever, drenching night sweats or infections that recur or do not clear should be discussed with a doctor.

  • Enlarged lymph nodes or abdominal swelling

    Lymphoma can cause lumps or swelling in these areas.

  • Bone or back pain

    Persistent or recurring pain can occur with myeloma; leukemia may also cause bone or joint pain.

These symptoms do not automatically mean cancer. Speak with a healthcare professional so the cause can be investigated.

Understand your risk of blood cancer

Risk Factors and Prevention

Risk factors differ across leukemia, lymphoma and myeloma. Discuss which parts of your history may matter for your diagnosis or risk.

  • Age and sex

    Many blood cancers become more common with age and are more common in men, but the pattern differs between diseases.

  • Family history

    A family history of blood cancer may be relevant.

  • Radiation and chemical exposure

    Some exposures can affect blood cancer risk.

  • Weight and general health

    Obesity is among the risk factors associated with some blood cancers.

Steps that may help lower risk: There are few established ways to prevent these cancers. Avoid tobacco, stay active, eat well and limit harmful exposures as part of healthy habits. These steps support general health and do not guarantee prevention. Ask your doctor about your own history and concerns.

How blood cancer is found — step by step

Screening and Diagnosis

There is no routine screening test for blood cancers comparable to a mammogram for breast cancer. Symptoms and other findings can lead to further investigation.

  1. Identify the specific disease

    Ask which tests establish the type of blood cancer and what the results mean.

  2. Blood and urine tests

    These can help identify changes associated with myeloma. Other tests depend on the suspected diagnosis.

  3. Examine the affected cells

    In lymphoma, examining the cells helps distinguish Hodgkin from non-Hodgkin disease.

  4. Review the report and cancer features

    Ask for a copy of your pathology report and an explanation of any results that guide treatment.

Understanding your results: Not everyone follows the same testing pathway. Ask whether further tests are needed and which results will guide the next care decision.

Explore your blood cancer treatment options

Treatment

Treatment discussions begin with the exact diagnosis, its characteristics, your health and your preferences. Options used for one blood cancer may not be suitable for another.

  • Chemotherapy

    Medicines are used to kill rapidly dividing cancer cells. The medicines and schedule depend on the disease.

  • Targeted therapy

    Medicines act on particular features involved in cancer growth. Ask whether testing identifies a relevant target.

  • Immunotherapy and cellular therapy

    Treatments help the immune system fight cancer. CAR T-cell therapy is used for selected blood cancers, including certain leukemias and lymphomas.

  • Stem cell transplantation

    This is an option in selected settings, including some leukemias and myeloma. Your team can explain its purpose and what it would involve.

  • Clinical trials

    Studies test new treatments or new ways of using existing treatments. Ask whether a trial may fit your diagnosis and care needs.

You don’t need to understand everything at once

What Happens After Diagnosis?

It is reasonable to need time to absorb a diagnosis. Start with a few questions, ask for written explanations and involve someone you trust when that helps.

Blood Cancer — A few steps can help

A few steps can help

  • Ask for the full name and subtype of your blood cancer.
  • Ask what your reports and test results mean.
  • Discuss the goal, benefits and side effects of each option.
  • Ask whether a clinical trial or second opinion is appropriate.
  • Bring a trusted person and write down questions for appointments.
  • Keep your reports, test results and next steps together.

NFCR · redesign.nfcr.org

Researchers in a lab examining a sample
NFCR research on blood cancer

The Future of Blood Cancer Research

Blood cancer research includes work on blood-forming stem cells, experimental compounds against leukemia cells and the genetic mechanisms that influence cancer growth and treatment resistance. These approaches address different questions and stages of development. Laboratory findings need further testing before they can become established treatments.

What NFCR Is Doing

We support research into blood-forming stem cells, experimental therapies and the genetic mechanisms of cancer. Curt Civin’s work on CD34 helped scientists isolate blood-forming stem cells for transplantation, and his later laboratory studies investigated compounds against AML cells. We began supporting Wei Zhang’s genomics research in 2006 and supported Michael Sporn’s chemoprevention research from 1999 to 2015. Our current and past-supported researchers address blood cancers and broader questions that may inform progress across cancer types.

Year Curt Civin discovered CD34, a marker that helped enable isolation of blood-forming stem cells
1984
Year we began supporting Wei Zhang’s cancer genomics research
2006
Years of our support for Michael Sporn’s research
1999–2015

Research makes cures possible

Every new discovery has the potential to change what we know about cancer — how it begins, how it spreads, how it can be detected, and how it can be treated.

Your support helps fund scientists working across cancer types to turn promising discoveries into life-saving options for patients.

Prefer to speak with someone? Call us to donate — 1-800-321-CURE.